Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
25-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
25-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #122144
advertisement
Pîrvulescu RA
22
Showing records 1 to 22 |
Display all abstracts from
Pîrvulescu RA
119807
Navigating Surgical Challenges: Managing Juvenile Glaucoma in a Patient with Dorfman-Chanarin Syndrome
Anton N
Biomedicines
2024; 12:
119045
A Mini-Review on Gene Therapy in Glaucoma and Future Directions
Anton N; Anton N
International journal of molecular sciences
2024; 25:
122616
Artificial intelligence in ophthalmology
Popescu Patoni SI
Romanian journal of ophthalmology
2023; 67: 207-213
119807
Navigating Surgical Challenges: Managing Juvenile Glaucoma in a Patient with Dorfman-Chanarin Syndrome
Anton N; Dohotariu FC
Biomedicines
2024; 12:
119045
A Mini-Review on Gene Therapy in Glaucoma and Future Directions
Geamănu A
International journal of molecular sciences
2024; 25:
122616
Artificial intelligence in ophthalmology
Muşat AAM
Romanian journal of ophthalmology
2023; 67: 207-213
119807
Navigating Surgical Challenges: Managing Juvenile Glaucoma in a Patient with Dorfman-Chanarin Syndrome
Pîrvulescu RA; Pîrvulescu RA
Biomedicines
2024; 12:
122616
Artificial intelligence in ophthalmology
Patoni C
Romanian journal of ophthalmology
2023; 67: 207-213
119807
Navigating Surgical Challenges: Managing Juvenile Glaucoma in a Patient with Dorfman-Chanarin Syndrome
Pîrvulescu RA
Biomedicines
2024; 12:
119045
A Mini-Review on Gene Therapy in Glaucoma and Future Directions
Iancu R; Pîrvulescu RA
International journal of molecular sciences
2024; 25:
122616
Artificial intelligence in ophthalmology
Popescu MN
Romanian journal of ophthalmology
2023; 67: 207-213
119045
A Mini-Review on Gene Therapy in Glaucoma and Future Directions
Pîrvulescu RA
International journal of molecular sciences
2024; 25:
119807
Navigating Surgical Challenges: Managing Juvenile Glaucoma in a Patient with Dorfman-Chanarin Syndrome
Barac IR
Biomedicines
2024; 12:
119045
A Mini-Review on Gene Therapy in Glaucoma and Future Directions
Pîrvulescu RA
International journal of molecular sciences
2024; 25:
119807
Navigating Surgical Challenges: Managing Juvenile Glaucoma in a Patient with Dorfman-Chanarin Syndrome
Bogdănici CM
Biomedicines
2024; 12:
119045
A Mini-Review on Gene Therapy in Glaucoma and Future Directions
Popa-Cherecheanu A
International journal of molecular sciences
2024; 25:
122616
Artificial intelligence in ophthalmology
Munteanu M
Romanian journal of ophthalmology
2023; 67: 207-213
119045
A Mini-Review on Gene Therapy in Glaucoma and Future Directions
Barac RI
International journal of molecular sciences
2024; 25:
122616
Artificial intelligence in ophthalmology
Costache IB
Romanian journal of ophthalmology
2023; 67: 207-213
119045
A Mini-Review on Gene Therapy in Glaucoma and Future Directions
Bandol G
International journal of molecular sciences
2024; 25:
122616
Artificial intelligence in ophthalmology
Pîrvulescu RA; Pîrvulescu RA; Pîrvulescu RA; Mușat O
Romanian journal of ophthalmology
2023; 67: 207-213
119045
A Mini-Review on Gene Therapy in Glaucoma and Future Directions
Bogdănici CM
International journal of molecular sciences
2024; 25:
Issue
25-1
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept